Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) has been assigned an average rating of "Moderate Buy" from the ten brokerages that are presently covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $75.44.
Several equities analysts recently issued reports on the company. Barclays reduced their price objective on Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating for the company in a report on Friday, November 22nd. Royal Bank of Canada cut their price target on Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating for the company in a research note on Monday, November 18th. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a "hold" rating to a "buy" rating and increased their price objective for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. Cantor Fitzgerald restated a "neutral" rating and set a $52.00 target price on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Finally, StockNews.com upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday, December 19th.
Get Our Latest Stock Report on Acadia Healthcare
Institutional Investors Weigh In On Acadia Healthcare
Hedge funds have recently made changes to their positions in the business. GAMMA Investing LLC lifted its position in Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company's stock worth $42,000 after buying an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Acadia Healthcare in the second quarter worth approximately $59,000. Covestor Ltd grew its holdings in Acadia Healthcare by 834.4% in the third quarter. Covestor Ltd now owns 1,140 shares of the company's stock valued at $72,000 after purchasing an additional 1,018 shares during the period. DekaBank Deutsche Girozentrale acquired a new position in Acadia Healthcare during the third quarter worth approximately $86,000. Finally, nVerses Capital LLC purchased a new position in Acadia Healthcare during the second quarter worth approximately $95,000.
Acadia Healthcare Price Performance
NASDAQ:ACHC traded down $0.11 during trading hours on Friday, hitting $37.96. The company's stock had a trading volume of 1,275,330 shares, compared to its average volume of 1,074,150. The business's 50-day moving average is $41.93 and its two-hundred day moving average is $59.74. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The company has a market capitalization of $3.53 billion, a PE ratio of 12.45, a PEG ratio of 1.77 and a beta of 1.29. Acadia Healthcare has a 52-week low of $36.50 and a 52-week high of $87.77.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. The company had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.91 earnings per share. As a group, research analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current fiscal year.
About Acadia Healthcare
(
Get Free ReportAcadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.